147 related articles for article (PubMed ID: 37952082)
1. Daily fraction dose-adjusted radiotherapy policy to avoid prolonging the overall treatment time for early glottic squamous cell carcinoma: a single-institutional retrospective study.
Dekura Y; Yasuda K; Minatogawa H; Uchinami Y; Tsushima N; Suzuki T; Kano S; Mori T; Nishioka K; Kobashi K; Katoh N; Homma A; Aoyama H
J Radiat Res; 2024 Jan; 65(1):63-70. PubMed ID: 37952082
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.
Moon SH; Cho KH; Chung EJ; Lee CG; Lee KC; Chai GY; Kang KM; Lee JY; Chung WK; Park WY; Kim JH
Radiother Oncol; 2014 Jan; 110(1):98-103. PubMed ID: 24161568
[TBL] [Abstract][Full Text] [Related]
3. Impact of radiation therapy fraction size on local control of early glottic carcinoma.
Yu E; Shenouda G; Beaudet MP; Black MJ
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):587-91. PubMed ID: 9112457
[TBL] [Abstract][Full Text] [Related]
4. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
[TBL] [Abstract][Full Text] [Related]
5. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Three Fractionation Schedules in Radiotherapy for Early Glottic Squamous Cell Carcinoma.
Suzuki G; Yamazaki H; Aibe N; Masui K; Shimizu D; Kimoto T; Nishimura T; Kawabata K; Nagasawa S; Machida K; Yoshino Y; Watanabe S; Sugiyama Y; Arai A; Hirano S; Yamada K
In Vivo; 2020; 34(5):2769-2774. PubMed ID: 32871813
[TBL] [Abstract][Full Text] [Related]
7. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
9. Accelerated radiotherapy for T1 to T2 glottic cancer.
Motegi A; Kawashima M; Arahira S; Zenda S; Toshima M; Onozawa M; Hayashi R; Akimoto T
Head Neck; 2015 Apr; 37(4):579-84. PubMed ID: 24677592
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.
Nishimura Y; Nagata Y; Okajima K; Mitsumori M; Hiraoka M; Masunaga S; Ono K; Shoji K; Kojima H
Radiother Oncol; 1996 Sep; 40(3):225-32. PubMed ID: 8940749
[TBL] [Abstract][Full Text] [Related]
11. Optimized treatment strategy of radiotherapy for early glottic squamous cell carcinomas: An initial analysis.
Kimura K; Itoh Y; Okada T; Kubota S; Kawamura M; Nakahara R; Oie Y; Kozai Y; Takase Y; Tsuzuki H; Nishio N; Hiramatsu M; Fujimoto Y; Mizutani T; Naganawa S
Nagoya J Med Sci; 2017 Aug; 79(3):331-338. PubMed ID: 28878438
[TBL] [Abstract][Full Text] [Related]
12. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
Garden AS; Morrison WH; Ang KK; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
[TBL] [Abstract][Full Text] [Related]
13. Clinical radiobiology of glottic T1 squamous cell carcinoma.
Skladowski K; Tarnawski R; Maciejewski B; Wygoda A; Slosarek K
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):101-6. PubMed ID: 9989520
[TBL] [Abstract][Full Text] [Related]
14. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
[TBL] [Abstract][Full Text] [Related]
15. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
16. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.
Fein DA; Mendenhall WM; Parsons JT; Million RR
Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):605-11. PubMed ID: 8454477
[TBL] [Abstract][Full Text] [Related]
17. Critical evaluation of a prospective study of concurrent chemoradiotherapy with S-1 for early glottic carcinoma.
Kimura K; Itoh Y; Okada T; Nakahara R; Kawamura M; Kubota S; Itoh J; Hiramatsu M; Fujimoto Y; Shibata T; Naganawa S
Anticancer Res; 2015 Apr; 35(4):2385-90. PubMed ID: 25862904
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of radiation therapy for T1 glottic carcinoma from an Italian regional series with doses ranging from 60 to 66 Gy.
Manzo R; Ravo V; Murino P; Morra A; Panetti G; Laudati A; Prisco A; Panelli G; Muto P
Tumori; 2010; 96(4):577-81. PubMed ID: 20968137
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
